4//SEC Filing
PURE BIOSCIENCE, INC. 4
Accession 0001209191-17-041856
$PURECIK 0001006028operating
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 4:59 PM ET
Size
8.1 KB
Accession
0001209191-17-041856
Insider Transaction Report
Form 4
Pfanzelter David J
Director
Transactions
- Award
Stock Options (Right to Buy)
2017-06-22+1,000,000→ 1,000,000 totalExercise: $1.19Exp: 2027-06-22→ Common Stock (1,000,000 underlying) - Award
Common Stock
2017-06-22+500,000→ 540,000 total
Footnotes (3)
- [F1]Represents the issuance of restricted stock units (the "RSUs"). 25% of the RSUs vest on December 31, 2018 with the remaining shares vesting in 3 equal annual installments thereafter. Vested shares will be delivered to the Reporting Person on the earlier of (i) the ten-year anniversary of the Grant Date; (ii) sixty days after the date the Grantee's Service ceases for any reason and such cessation constitutes a "separation from service" within the meaning of Section 409A of the Code; (iii) the date of Grantee's death or (iv) the date of a Change in Control that constitutes a "change in control event" within the meaning of Section 409A of the Code.
- [F2]Reflects the cancellation of 2,800,000 Restricted Stock Units pursuant to an RSU Cancellation Agreement, dated December 13, 2016.
- [F3]25% of the option shares shall vest and become exercisable on December 31, 2018 with the remaining shares vesting in 3 equal annual installments thereafter.
Documents
Issuer
PURE BIOSCIENCE, INC.
CIK 0001006028
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001006028
Filing Metadata
- Form type
- 4
- Filed
- Jun 25, 8:00 PM ET
- Accepted
- Jun 26, 4:59 PM ET
- Size
- 8.1 KB